MCC
AXDX

Mid Continent Capital’s Accelerate Diagnostics AXDX Stock Holding History

Mid Continent Capital’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$247K Hold
1,529
– – 0.02% 247
2015
Q2 		$395K Hold
1,529
– – 0.02% 252
2015
Q1 		$344K Hold
1,529
– – 0.02% 258
2014
Q4 		$293K Hold
1,529
– – 0.02% 265
2014
Q3 		$328K Buy
1,529
+1
+0.1% +$194 0.02% 265
2014
Q2 		$397K Sell
1,528
-68
-4% -$14.8K 0.02% 244
2014
Q1 		$348K Hold
1,596
– – 0.02% 255
2013
Q4 		$195K Hold
1,596
– – 0.01% 313
2013
Q3 		$214K Buy
1,596
+96
+6% +$8.57K 0.02% 292
2013
Q2 		$122K Buy
+1,500
New +$111K 0.01% 295

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return

Mid Continent Capital's AXDX Position: Q3 2015 in Review

Mid Continent Capital held its Accelerate Diagnostics (AXDX) position steady in Q3 2015 at 1,529 shares worth $247K. The position accounts for 0.02% of the portfolio, ranked #247.

Mid Continent Capital first reported a position in AXDX in Q2 2013 and has held it in 10 quarters since. The position peaked at $397K in Q2 2014. 88 funds tracked by Wall St. Rank hold AXDX as of Q3 2015.

  • Mid Continent Capital held 1,529 shares of Accelerate Diagnostics worth $247K as of Q3 2015.
  • Mid Continent Capital left its Accelerate Diagnostics share count unchanged in Q3 2015.
  • Accelerate Diagnostics made up 0.02% of Mid Continent Capital's portfolio in Q3 2015, its #247 holding.
  • Mid Continent Capital first reported a position in Accelerate Diagnostics in Q2 2013 and has held it in 10 quarters since.
  • Mid Continent Capital's Accelerate Diagnostics position peaked at $397K in Q2 2014.
  • 88 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.